DK165440C - Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele - Google Patents

Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele

Info

Publication number
DK165440C
DK165440C DK519387A DK519387A DK165440C DK 165440 C DK165440 C DK 165440C DK 519387 A DK519387 A DK 519387A DK 519387 A DK519387 A DK 519387A DK 165440 C DK165440 C DK 165440C
Authority
DK
Denmark
Prior art keywords
main components
urinents
propylengylycol
polyethylengylycol
pharmaceutical preparations
Prior art date
Application number
DK519387A
Other languages
Danish (da)
English (en)
Other versions
DK165440B (da
DK519387A (da
DK519387D0 (da
Inventor
Sven Moberg
Original Assignee
Sven Moberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Moberg filed Critical Sven Moberg
Publication of DK519387A publication Critical patent/DK519387A/da
Publication of DK519387D0 publication Critical patent/DK519387D0/da
Publication of DK165440B publication Critical patent/DK165440B/da
Application granted granted Critical
Publication of DK165440C publication Critical patent/DK165440C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
DK519387A 1986-02-04 1987-10-02 Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele DK165440C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8600501A SE462139B (sv) 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
SE8600501 1986-02-04
PCT/SE1987/000053 WO1987004617A1 (en) 1986-02-04 1987-02-04 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE8700053 1987-02-04

Publications (4)

Publication Number Publication Date
DK519387A DK519387A (da) 1987-10-02
DK519387D0 DK519387D0 (da) 1987-10-02
DK165440B DK165440B (da) 1992-11-30
DK165440C true DK165440C (da) 1993-04-13

Family

ID=20363358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK519387A DK165440C (da) 1986-02-04 1987-10-02 Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele

Country Status (9)

Country Link
EP (1) EP0292495B1 (de)
AT (1) ATE67409T1 (de)
AU (1) AU599086B2 (de)
CA (1) CA1330198C (de)
DE (1) DE3773201D1 (de)
DK (1) DK165440C (de)
NO (1) NO174764C (de)
SE (1) SE462139B (de)
WO (1) WO1987004617A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5464610A (en) 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
DE4322395C1 (de) * 1993-07-01 1994-07-28 Kuehnl Petzoldt Christa Dr Med Duschlotion zur Behandlung und Pflege trockener Haut
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5916545A (en) * 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
SE9403541L (sv) * 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
EP0957903B1 (de) * 1996-09-18 2005-08-10 Applied Genetics Incorporated Dermatics Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen
AU754420B2 (en) * 1997-11-25 2002-11-14 Leo Pharma A/S Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
DE69932922T2 (de) * 1998-02-13 2007-05-03 Buck, Carol J. Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
US6858215B2 (en) 2002-06-14 2005-02-22 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US6835385B2 (en) 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
CA2492976C (en) * 2002-09-05 2011-11-01 Galderma Research & Development, S.N.C. Solution for ungual and peri-ungual application
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
WO2005115368A1 (en) * 2004-05-31 2005-12-08 Al Tayeb Fayez Hussien Carrier composition for topical formulations
EP1683511A1 (de) * 2005-01-13 2006-07-26 Laboratoires S.V.R. Harnstoof enthaltende Schuppen-regulierende zusammensetzung und ihre dermatologische verwendung
EP1965757B1 (de) 2005-11-14 2016-11-23 L'Oréal Kosmetische verwendung eines hydroxyalkyl-harnstoffs als mittel zur behandlung desquamativer leiden der kopfhaut sowie zusammensetzung und verfahren zur kosmetischen anwendung
WO2008046796A2 (en) * 2006-10-20 2008-04-24 Symrise Gmbh & Co. Kg Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US20140205639A1 (en) * 2013-01-22 2014-07-24 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2316436A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Film, insbesondere einem löslichen Film, mit mindestens einem Enzym
EP2316438A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Hyperkeratosehemmer und/oder mindestens einem keratinolytischem Wirkstoff
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
WO2012110430A1 (en) 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
EA024483B1 (ru) * 2011-05-12 2016-09-30 Аукзилиум Кура Инноватио Местная композиция для лечения гиперкератотической кожи
WO2014140507A1 (en) 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395236A (en) * 1961-09-28 1968-07-30 Cleveland J. White Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
SE325667B (de) * 1968-03-06 1970-07-06 Medisan Ab
DE2608221B1 (de) * 1976-02-28 1977-07-21 Beiersdorf Ag Kosmetisches mittel zur glaettung der haut
US4239781A (en) * 1979-05-03 1980-12-16 Roy Edwards Method for treating skin ailments
DE3210138A1 (de) * 1982-03-19 1983-09-22 Röhm Pharma GmbH, 6100 Darmstadt Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis
AU570998B2 (en) 1983-09-07 1988-03-31 Takeda Chemical Industries Ltd. Topical steroid compositions for acne

Also Published As

Publication number Publication date
AU599086B2 (en) 1990-07-12
AU7023987A (en) 1987-08-25
EP0292495A1 (de) 1988-11-30
EP0292495B1 (de) 1991-09-18
SE8600501D0 (sv) 1986-02-04
WO1987004617A1 (en) 1987-08-13
SE462139B (sv) 1990-05-14
NO874150L (no) 1987-12-02
ATE67409T1 (de) 1991-10-15
DK165440B (da) 1992-11-30
NO174764C (no) 1994-07-06
CA1330198C (en) 1994-06-14
DE3773201D1 (de) 1991-10-24
DK519387A (da) 1987-10-02
SE8600501L (sv) 1987-08-05
NO174764B (no) 1994-03-28
DK519387D0 (da) 1987-10-02
NO874150D0 (no) 1987-10-02

Similar Documents

Publication Publication Date Title
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
PE799A1 (es) Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DK645488A (da) Topiske metronidazol-praeparater og terapeutiske anvendelser deraf
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
IT8121849A0 (it) Procedimento per la preparazione di un agente anti-microbico, composizioni che lo contengono eloro uso nel trattamento di infezioni.
BR9106272A (pt) Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo
ES495826A0 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
ATE8880T1 (de) Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5&#39;-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE43950T1 (de) Antiseptisches produkt und verfahren zu seiner herstellung.
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
AR002258A1 (es) Derivados de fenoxipirimidinilo, preparaciones farmaceuticas que los contienen, un procedimiento para su preparacion y su empleo para preparar medicamentos
TH39154B (th) องค์ประกอบของเครื่องสำอาง

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK